BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/26/2021 11:20:59 AM | Browse: 602 | Download: 1273
 |
Received |
|
2020-12-23 23:48 |
|
Peer-Review Started |
|
2020-12-23 23:49 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-02-11 03:27 |
|
Revised |
|
2021-02-26 01:10 |
|
Second Decision |
|
2021-07-05 05:44 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2021-07-05 08:34 |
|
Articles in Press |
|
2021-07-05 08:34 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2021-07-10 20:51 |
|
Typeset the Manuscript |
|
2021-07-20 06:50 |
|
Publish the Manuscript Online |
|
2021-07-26 11:20 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Minireviews |
| Article Title |
Addition of statins to the standard treatment in patients with cirrhosis: Safety and efficacy
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Alberto E Muñoz, Florencia D Pollarsky, Mónica Marino, Mariano Cartier, Horacio Vázquez, Pablo Salgado and Gustavo Romero |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Alberto E Muñoz, MD, Assistant Professor, Associate Specialist, Attending Doctor, Medical Assistant, Staff Physician, Sección Hepatología, Hospital de Gastroenterología Dr. Carlos Bonorino Udaondo, Facultad de Medicina, Universidad de Buenos Aires, Av, Caseros 2061, Ciudad Autónoma de Buenos Aires 1264, Argentina. aemunoz@intramed.net |
| Key Words |
Cirrhosis; Liver disease; Statins; Safety; Efficiency |
| Core Tip |
Several observational studies of statins in patients with liver disease were published, but they were highly biased. On the other hand, only one randomized controlled trial (RCT) improved survival in Child-Pugh class A/B patients but did not reduce variceal rebleeding. Finally, the dose and type of statin to be used should be defined. This review concludes that news RCTs are necessary before endorsing statins use in patients with chronic liver disease. |
| Publish Date |
2021-07-26 11:20 |
| Citation |
Muñoz AE, Pollarsky FD, Marino M, Cartier M, Vázquez H, Salgado P, Romero G. Addition of statins to the standard treatment in patients with cirrhosis: Safety and efficacy. World J Gastroenterol 2021; 27(28): 4639-4652 |
| URL |
https://www.wjgnet.com/1007-9327/full/v27/i28/4639.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v27.i28.4639 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
